Z Yang, J Gong, J Li, H Sun, Y Pan… - International Journal of …, 2023 - journals.lww.com
Background: Due to tumoral heterogeneity and the lack of robust biomarkers, the prediction of chemoradiotherapy response and prognosis in patients with esophageal cancer (EC) is …
B Xue, J Jiang, L Chen, S Wu, X Zheng, X Zheng… - Frontiers in …, 2021 - frontiersin.org
Objectives The aim of this study was to develop a preoperative positron emission tomography (PET)-based radiomics model for predicting peritoneal metastasis (PM) of …
YS Kao, YEN Hsu - in vivo, 2021 - iv.iiarjournals.org
Background: Preservation of organ function is important in cancer treatment. The 'watch-and- wait'strategy is an important approach in management of esophageal cancer. However …
Y Liu, Y Wang, X Wang, L Xue, H Zhang, Z Ma, H Deng… - Cancer Imaging, 2024 - Springer
Background More than 40% of patients with resectable esophageal squamous cell cancer (ESCC) achieve pathological complete response (pCR) after neoadjuvant …
N Menon, N Guidozzi, S Chidambaram… - Diseases of the …, 2023 - academic.oup.com
Radiomics can interpret radiological images with more detail and in less time compared to the human eye. Some challenges in managing esophageal cancer can be addressed by …
S Lu, C Wang, Y Liu, F Chu, Z Jia, H Zhang, Z Wang… - European …, 2024 - Springer
Objectives To investigate the MRI radiomics signatures in predicting pathologic response among patients with locally advanced esophageal squamous cell carcinoma (ESCC), who …
M Zhang, Y Lu, H Sun, C Hou, Z Zhou, X Liu… - Translational …, 2024 - Elsevier
Purpose To evaluate and validate CT-based models using pre-and posttreatment deep learning radiomics features and hematological biomarkers for assessing esophageal …
L Deantonio, ML Garo, G Paone, MC Valli… - Frontiers in …, 2022 - frontiersin.org
The best treatment strategy for oesophageal cancer patients achieving a complete clinical response after neoadjuvant chemoradiation is a burning topic. The available diagnostic …
Y Liu, Z Ma, Y Bao, X Wang, Y Men, X Sun, F Ye… - Heliyon, 2024 - cell.com
Purpose We aimed to integrate MR radiomics and dynamic hematological factors to build a model to predict pathological complete response (pCR) to neoadjuvant chemoradiotherapy …